⚠️ Compounded Retatrutide Is ILLEGAL

FDA explicitly prohibits compounded retatrutide under federal law. Any source claiming to sell it is breaking the law and putting your health at risk.

Quick Facts About Compounded Retatrutide

❌ Legal Status: PROHIBITED under federal law (FDA, 2025)
❌ Current Availability: ONLY available in FDA-approved clinical trials
⚠️ Expected FDA Approval: Late 2026 or early 2027
✅ Legal Alternative NOW: Tirzepatide (15-22.5% weight loss, FDA-approved, available through telehealth)

Why Compounded Retatrutide Is Illegal Under Federal Law

The FDA has issued explicit warnings that retatrutide cannot be used in compounding under federal law. Here's why:

Not FDA-Approved: Retatrutide is still in Phase 3 clinical trials
Not on FDA's Bulks List: Cannot be compounded under Section 503A/503B
Safety Concerns: Classified as "substance with safety concerns"
Investigational Status: Only available in Eli Lilly clinical trials

Legal Alternatives to Compounded Retatrutide (Available NOW)

Instead of risking your health with illegal sources, use these FDA-approved alternatives available TODAY:

Medvi

$179/mo

Tirzepatide • First month (save $120)

15-22.5% weight loss
FDA-approved
Ships to all 50 states

Get Started →

Remedy Meds

$299/mo

Tirzepatide • Premium service

15-22.5% weight loss
Fast turnaround
Personalized support

Get Started →

Ro

$349/mo

Tirzepatide or Semaglutide

Choose your peptide
Comprehensive program
Medical supervision

Get Started →

Safety Risks of Underground Retatrutide Sources

If you encounter websites, social media sellers, or "research chemical" vendors claiming to sell retatrutide, understand these critical risks:

Unknown purity: May be 20-80% pure vs. 99%+ pharmaceutical grade
Contamination risk: Bacterial, heavy metal, or other contaminants
Mislabeling: May not even be retatrutide
Dosing errors: Can lead to overdose or underdose
No legal recourse: If harmed, you have zero protection

When Will Retatrutide Be Legally Available?

Based on clinical trial timelines and FDA approval processes:

Q2-Q4 2026: Phase 3 trial results expected
Q4 2026: FDA submission (if trials successful)
Q4 2026 - Q3 2027: FDA review period (10-12 months)
Best case: Q4 2026 approval
Realistic: Q2-Q3 2027 approval

Smart Strategy: Start Tirzepatide NOW, Switch Later

Don't wait 18-24 months for retatrutide. Start tirzepatide today and lose 15-22.5% of your body weight. You can always transition to retatrutide when it becomes available.

Start Losing Weight TODAY with Legal, FDA-Approved Tirzepatide

15-22.5% weight loss • $179-499/month • Available NOW through telehealth

Get Started with Medvi ($179/mo) →